MUC16 and benign neoplasm: CA‐125, a widely used Food and Drug Administration (FDA) approved marker for OC detection, sometimes fails to detect OCs due to its lower limit of detection (LLOD; <35 IU/mL) and the occurrence of false positive results in benign tumors due to specificity issues.21